GAETA, Giovanni Battista
 Distribuzione geografica
Continente #
EU - Europa 5.082
NA - Nord America 4.884
AS - Asia 612
Continente sconosciuto - Info sul continente non disponibili 17
SA - Sud America 16
AF - Africa 11
OC - Oceania 3
Totale 10.625
Nazione #
US - Stati Uniti d'America 4.859
IE - Irlanda 1.785
UA - Ucraina 956
GB - Regno Unito 760
DE - Germania 430
CN - Cina 427
SE - Svezia 289
IT - Italia 276
FI - Finlandia 217
GR - Grecia 175
TR - Turchia 127
FR - Francia 121
BE - Belgio 32
CA - Canada 19
IR - Iran 16
EU - Europa 15
IN - India 14
PL - Polonia 12
NL - Olanda 10
BR - Brasile 7
CH - Svizzera 6
ET - Etiopia 5
MX - Messico 5
SG - Singapore 5
BO - Bolivia 4
KR - Corea 4
TW - Taiwan 3
VN - Vietnam 3
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
AR - Argentina 2
AU - Australia 2
BF - Burkina Faso 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HK - Hong Kong 2
ID - Indonesia 2
JP - Giappone 2
NO - Norvegia 2
PE - Perù 2
SC - Seychelles 2
TH - Thailandia 2
AM - Armenia 1
AT - Austria 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CO - Colombia 1
ES - Italia 1
GL - Groenlandia 1
HU - Ungheria 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 10.625
Città #
Dublin 1.779
Jacksonville 1.401
Chandler 893
Princeton 271
Medford 236
Boardman 156
Roxbury 140
San Mateo 130
Wilmington 122
Ann Arbor 108
Beijing 108
Woodbridge 83
Bremen 77
Cambridge 72
New York 63
Nanjing 60
Des Moines 52
Düsseldorf 47
Ashburn 46
Mountain View 40
Jinan 35
Brussels 32
Caserta 29
Nanchang 27
Venice 26
Napoli 25
Norwalk 21
Shenyang 21
Zhengzhou 20
Los Angeles 18
Rome 18
Kunming 17
Guangzhou 15
Tianjin 14
Changsha 13
Ningbo 12
Redwood City 11
Shanghai 11
Haikou 10
Hebei 10
Ottawa 10
Auburn Hills 9
Kraków 9
Lanzhou 8
Milan 8
Taizhou 8
Houston 7
Munich 7
Hangzhou 6
Padova 6
West Jordan 6
Zanjan 6
Groningen 5
Guadalajara 5
Jiaxing 5
Menlo Park 5
Andover 4
Bagheria 4
La Paz 4
London 4
Naples 4
Orange 4
Pittsburgh 4
Toronto 4
Atlanta 3
Catania 3
Changchun 3
Erice 3
Glis 3
Helsinki 3
Leawood 3
Namakkal 3
Palermo 3
Pinerolo 3
Sacramento 3
Seoul 3
Taipei 3
Taiyuan 3
Walnut 3
Aversa 2
Bologna 2
Brembate 2
Brescia 2
Burnips 2
Cedar Knolls 2
Chaoyang 2
Chiang Mai 2
Dallas 2
Dong Ket 2
Edinburgh 2
Falls Church 2
Fremont 2
Gioi 2
Grafing 2
Haiger 2
Hefei 2
Henderson 2
Lima 2
Marano Di Napoli 2
Nashville 2
Totale 6.498
Nome #
ANTI TNF ALFA IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE E SPONDILOARTRITI HBV CARRIERS OCCULTI:STUDIO RETROSPETTIVO SULLA SICUREZZA 194
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients 155
Detection of in vivo hepatitis B virus surface antigen mutations-A comparison of four routine screening assays 153
1) Analisi delle discontinuità di distribuzione e dei tempi di accumulo di radiocolloide in epatopatici cronici: risultati preliminari 121
ANTI-TNFα TREATMENT IS ASSOCIATED WITH INCREASED LIVER STIFFNESS IN HBV OCCULT CARRIER PATIENTS 84
Ittero in corso di infezione delle vie urinarie. Presentazione di un caso clinico ed aspetti patogenetici 78
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life 73
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 68
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 68
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 66
Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance 63
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues. 61
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 61
Active recruitment strategy in disadvantaged immigrant populations improves the identification of human immunodeficiency but not of hepatitis B or C virus infections 59
Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin 59
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients. 59
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma. A Cancer of the Liver Italian Program (CLIP 08)retrospective case-control study 58
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP) 57
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 57
Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial 57
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 57
Endotoxin protects against chlorpromazine-induced cholestasis in the isolated perfused rat liver 57
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 57
Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study 56
Influenza vaccination in patients with cirrhosis and in liver transplant recipients 56
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 55
Fever of unknown origin: a systematic review of the literature for 1995-2004 55
AISF position paper on liver disease and pregnancy 55
Doctors in the kitchen. Experiments with cooking bivalve mollusks 54
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 54
Effects of bacterial lipopolysaccharide (LPS) on chlorpromazine (CPZ) induced cholestasis in the isolated perfused rat liver 54
Hepatitis C virus infection in Italy: a multicentric sero-epidemiological study. (A report from the HCV study group of the Italian Association for the study of the liver) 52
Liver's functional alterations produced from erythromycin estolate in the isolated and perfused rat liver 52
Adefovir dipivoxil-associated thrombocytopenia in a patient with chronic hepatitis B 52
Bacterial endotoxin treatment ameliorates erythromycin estolate-induced cholestasis in the isolated perfused rat liver 52
Chronic endotoxin pretreatment protects from the chlorpromazine induced cholestasis 52
Pretreatment of isolated rat hepatocytes with endotoxin decreases erythromicin estolate - induced aspartate transaminase release 52
Effect of bile acids on hepatic metabolism and biliary secretion of 16:0-(14C) 18:2 phosphatidylcholine 52
Endotoxin reduces erythromycine estolate-induced releas of aspartate transaminase from isolated rat liver cells 51
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta 51
The role of surgery in transmitting "post-transfusion" hepatitis 51
Fattori di rischio per l'infezione tifoidea nell'area geografica del golfo di Napoli 51
3. HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years. 51
Epidemiology of hepatitis B virus (HBV) in Italy 51
Discriminating value of serum bile acids in asymptomatic HBsAg carriers 51
Rapid improvement of hepatic encephalopathy associated with oral ciprofloxacin treatment 50
Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver 50
Absence of mutations in the YMDD motif/B region of the hepatitis B polymerase in famciclovir therapy failure 50
IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C 50
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy 50
Cholestasis induced by estradiol-17 beta-D-glucuronide: mechanisms and prevention by sodium taurocholate 50
Influence of tauroursodeoxycholic and taurodeoxycholic acids on hepatic metabolism and biliary secretion of phosphatidylcholine in the isolated rat liver 50
Reduction of taurolithocholic acid-induced cholestasis in the isolated perfused rat liver by endotoxin treatment 50
Potentation of ethanol-induced narcosis in mice by pretreatment with bacterial lipopolysaccharide 50
Bacterial endotoxin effect on liver plasma membranes (LPM): membrane-bound enzymes as probes of the site of interaction 50
Cholestatic effect of amphotericin B on the isolated perfused rat liver. Preliminary study 49
Liver toxicity during copper chronic intoxication in rats 49
Hepatic excretory function in the endotoxin tolerant rat 49
AASLD Practice Guidelines on chronic hepatitis B and HBV infection in Italy 49
Epidemiology of viral hepatitis in Italy 49
Effect of chronic copper administration on excretory function of rat liver 49
Endotoxin treatment may modulate the expression of hepatotoxicity of membrane-active agents. 49
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) 48
Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy 48
The homeostasis model assessment of insulin resistance score is not predictive of sustained virologic response in chronic hepatiti s C patients 48
Baseline HBV-DNA level is an important predictor of response to interferon in children with chronic hepatitis B 48
Endotoxin treatment of isolated hepatocytes reduces chlorpromazine-induced aspartate transaminase release 48
Efficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent adult patients 47
Hepatitis B in pregnancy. 47
Amphotericin B-induced depression in the phagocytic function of the isolated rat liver and its prevention by nifedipine 47
Effect of pretreatment with bacterial endotoxin on erythromycin estolate-induced cholestasis 47
Effetto della eritromicina sulle funzioni escretorie del fegato di ratto isolato 47
Metabolic changes associated with endotoxin tolerance: effect on bile secretion 46
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure 46
Studio prospettico controllato del trattamento prednisone interferone in pazienti pediatrici con epatite cronica da HBV 46
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required? 46
Hepatitis delta infection in Italian patients: towards the end of the story? 46
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 46
Virological patterns of HCV patients with failure to interferon-free regimens. 46
Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study 45
Successful treatment with ciprofloxacin of Salmonella typhimurium infection in an immunocompromised host 45
Tamoxifen in the treatmnent of hepatocellular carcinoma: 5 years results of the CLIP-1 multicentre randomised controlled trial 45
Evolving Clinical Landscape of Chronic Hepatitis B:A Multicenter Italian Study 45
[Spontaneous bacterial peritonitis in patients with liver cirrhosis. Differential aspects with portal thrombosis] 45
Clearance of viable salmonella typhi Ty 2 and Staphylococcus aureus by the isolated rat liver in the absence of serum factors 45
Salvage therapy with tenofovir followed by adefovir maintenance in a cirrhotic patient with a lamivudine resistant HBV flare. 45
Etiological, clinical and laboratory data of post-transfusion hepatitis: a retrospective study of 379 cases from 53 Italian hospitals 45
AISF position paper on HCV in immunocompromised patients 45
Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop 44
Does an "autoimmune"profile affect the clinical profile of chronic hepatitis C? An italian multicentre survey 44
HBsAg carriers among blood donors in Italy; a retrospective survey of data from 189 blood banks 44
Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature 44
Effects of endotoxins on hepatic excretory function 44
Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease 43
Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study 43
Clinical and histological aspects of chronic HCV infection and cirrhosis 43
Treatment of chronic Hepatitis C: a smart coat over a ragged dress? 43
Taurocholate but not dehydrocholate can reverse the cholestatic effects of estradiol-17-B-glucuronide in the isolated perfused rat liver 43
Bacterial infections and sepsis in cirrhotic patients increase apoptosis of circulating leucocyte 43
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study 42
Totale 5.547
Categoria #
all - tutte 40.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201927 0 0 0 0 0 0 0 0 0 0 15 12
2019/20201.360 264 259 13 12 238 14 269 61 129 43 50 8
2020/20211.987 202 11 237 92 372 22 272 220 13 264 222 60
2021/20221.690 148 11 17 62 590 14 30 65 70 97 132 454
2022/20233.346 293 45 38 302 311 286 6 216 1.694 26 56 73
2023/2024897 113 34 51 110 438 75 10 35 4 25 2 0
Totale 10.908